Keith R. Leonard, Jr.

Keith R. Leonard, Jr. has been a member of our Board of Directors since January 2016. Mr. Leonard has more than 20 years of experience in the pharmaceutical industry and has served as the chairman of the board of Unity Biotechnology, Inc., a biotechnology company, since October 2016, and was CEO from January 2016 to March 2020.

Previously, Mr. Leonard was president, chief executive officer, and a member of the Board of Directors of Kythera Biopharmaceuticals, Inc., a biopharmaceutical company that he co-founded, which focused on discovering, developing, and commercializing drugs for the aesthetic medicine market, from 2005 until its acquisition by Allergan plc in October 2015.

Mr. Leonard worked across numerous areas at Amgen, Inc. from 1991 to 2004, leading various functions including engineering, information technology, and ultimately as general manager of Amgen Europe.

He has served on the Board of Directors of Arcutis Biotherapeutics, Inc. since September 2021 along with several private companies. He also served on the Boards of Directors of Anacor Pharmaceuticals, Inc., from June 2014 to June 2016 and Sienna Biopharmaceuticals, Inc., from February 2016 to December 2019.

Mr. Leonard earned a BS in engineering from the University of California, Los Angeles, a BA in history from the University of Maryland, an MS in engineering from the University of California, Berkeley, and an MBA from the Anderson School of Management at the University of California, Los Angeles.